Miguel Vazquez-Moreno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Miguel Vazquez-Moreno has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Miguel Cruz
Unidad de Investigación Médica en Bioquímica, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City 06720, Mexico
17 shared publications - Ana Nava-Cabrera
Unidad de Investigación Médica en Bioquímica, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico
5 shared publications - Jaime Gomez-Zamudio
Unidad de Investigación Médica en Bioquímica, Hospital de Especialidades “Bernardo Sepulveda”, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico
5 shared publications - Adrián Hernández-Díazcouder
Unidad de Investigación Médica en Bioquímica, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City 06720, Mexico
3 shared publications - Araceli Pérez-Bautista
OOAD DF Norte del Instituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 23., Mexico City 07070, Mexico
3 shared publications - Eugenia Flores-Alfaro
Universidad Autónoma de Guerrero, México
3 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (10) , 2130
Pediatric Microbiota: Evidence and Future Perspectives—A Conference Report
During early life, the human microbiota contributes to the development of immune, metabolic, and neurological functions. Antibiotic exposure, inflammation, and dietary changes can alter microbial community structure and function, with potential implications for pediatric health. In April 2026, the symposium “Pediatric Microbiota: Evidence and Future” was held in Mexico City, bringing together experts to discuss current advances in pediatric microbiome research. This conference report summarizes the major topics and perspectives presented during the symposium. Several presentations examined how microorganisms and microbial metabolites are transferred from mother to infant. The speakers also discussed the contribution of colostrum immunoglobulins, particularly IgA, to early microbial colonization. Sessions reviewed evidence supporting probiotic use in pediatric gastrointestinal disorders and explored the microbiota–gut–brain axis in autism spectrum disorder and sleep regulation. In addition, speakers discussed the interactions among diet, starch digestion, microbial fermentation, and metabolic health, and their associations with obesity, insulin resistance, and cardiometabolic risk. Important knowledge gaps were identified in pediatric oncology, where evidence remains limited regarding the microbiome’s influence on cancer susceptibility, immune responses, treatment outcomes, and therapy-related toxicities. Participants agreed that the field would benefit from longitudinal studies in well-characterized pediatric cohorts, particularly in Latin America, as well as from studies examining biological mechanisms through multi-omics approaches. This research could eventually inform precision nutrition and microbiome-based interventions, but the evidence discussed at the symposium was not considered sufficient to support their routine clinical use.
- 22 September 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (10) , 2130
Open AccessPediatric Microbiota: Evidence and Future Perspectives—A Conference Report
During early life, the human microbiota contributes to the development of immune, metabolic, and neurological functions. Antibiotic exposure, inflammation, and dietary changes can alter microbial community structure and function, with potential implications for pediatric health. In April 2026, the symposium “Pediatric Microbiota: Evidence and Future” was held in Mexico City, bringing together experts to discuss current advances in pediatric microbiome research. This conference report summarizes the major topics and perspectives presented during the symposium. Several presentations examined how microorganisms and microbial metabolites are transferred from mother to infant. The speakers also discussed the contribution of colostrum immunoglobulins, particularly IgA, to early microbial colonization. Sessions reviewed evidence supporting probiotic use in pediatric gastrointestinal disorders and explored the microbiota–gut–brain axis in autism spectrum disorder and sleep regulation. In addition, speakers discussed the interactions among diet, starch digestion, microbial fermentation, and metabolic health, and their associations with obesity, insulin resistance, and cardiometabolic risk. Important knowledge gaps were identified in pediatric oncology, where evidence remains limited regarding the microbiome’s influence on cancer susceptibility, immune responses, treatment outcomes, and therapy-related toxicities. Participants agreed that the field would benefit from longitudinal studies in well-characterized pediatric cohorts, particularly in Latin America, as well as from studies examining biological mechanisms through multi-omics approaches. This research could eventually inform precision nutrition and microbiome-based interventions, but the evidence discussed at the symposium was not considered sufficient to support their routine clinical use.
- Open Access
- 10 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (8) , 3396
Differential Expression of microRNAs in Obese Mexican Children: Links to Insulin Resistance and Dyslipidemia
To analyze, in an analytical cross-sectional observational study, the relationship between the plasma microRNA (miRNA) expression profile in children living with obesity and their metabolic health status. Based on body mass index percentiles (BMIp), the children were grouped into a control group (C) or an obesity group (Ob). Glucose, insulin, and low- and high-density lipoproteins (LDLs and HDLs, respectively), triacylglycerols (TG), and total cholesterol (TC) were measured. RNA from plasma was used for miRNA sequencing analysis (NextSeq 2000 platform). Differential miRNA expression was determined using counts obtained from the reference genome. Fifty controls (BMIp: 50.4 ± 23) and fifty children with obesity (BMIp: 97.54 ± 1.46) were included. The obese group presented hyperinsulinemia and insulin resistance. Sequencing revealed nine underexpressed and six overexpressed miRNAs in the obese group. In silico analysis suggested that these miRNAs may participate in regulating insulin secretion, protein synthesis, apoptosis, and the glycolytic pathway in pancreatic β-cells. Childhood obesity was associated with altered circulating levels of microRNAs linked to glucose metabolism, insulin resistance (IR) and β-cell survival. Reduced plasma levels of miR-126-3p, let-7a-5p, and miR-16-5p showed a high predictive value for hypertriglyceridemia and insulin resistance, indicating their potential relevance as early biomarkers or therapeutic targets in pediatric metabolic dysfunction.
- 10 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (8) , 3396
Open AccessDifferential Expression of microRNAs in Obese Mexican Children: Links to Insulin Resistance and Dyslipidemia
To analyze, in an analytical cross-sectional observational study, the relationship between the plasma microRNA (miRNA) expression profile in children living with obesity and their metabolic health status. Based on body mass index percentiles (BMIp), the children were grouped into a control group (C) or an obesity group (Ob). Glucose, insulin, and low- and high-density lipoproteins (LDLs and HDLs, respectively), triacylglycerols (TG), and total cholesterol (TC) were measured. RNA from plasma was used for miRNA sequencing analysis (NextSeq 2000 platform). Differential miRNA expression was determined using counts obtained from the reference genome. Fifty controls (BMIp: 50.4 ± 23) and fifty children with obesity (BMIp: 97.54 ± 1.46) were included. The obese group presented hyperinsulinemia and insulin resistance. Sequencing revealed nine underexpressed and six overexpressed miRNAs in the obese group. In silico analysis suggested that these miRNAs may participate in regulating insulin secretion, protein synthesis, apoptosis, and the glycolytic pathway in pancreatic β-cells. Childhood obesity was associated with altered circulating levels of microRNAs linked to glucose metabolism, insulin resistance (IR) and β-cell survival. Reduced plasma levels of miR-126-3p, let-7a-5p, and miR-16-5p showed a high predictive value for hypertriglyceridemia and insulin resistance, indicating their potential relevance as early biomarkers or therapeutic targets in pediatric metabolic dysfunction.
- 5 March 2026
- Published by Springer Nature in Exposure and Health
- Vol. 18 (2) , 18
Serum Lead Levels are Associated with Mild Cognitive Impairment Risk in Underweight Older Adults
- 5 March 2026
- Published by Springer Nature in Exposure and Health
- Vol. 18 (2) , 18
Serum Lead Levels are Associated with Mild Cognitive Impairment Risk in Underweight Older Adults
- Open Access
- 24 November 2025
- Published by Springer Nature in International Journal of Obesity
- Vol. 50 (2) , 378-385
Serum S100β and neuron-specific enolase correlate with obesity parameters in Mexican children
Background: Circulating S100 β and neuron-specific enolase (NSE) have been used to explore brain damage in adults with obesity. Nonetheless, the subtle increase of these molecules can be found in non-pathological conditions in healthy subjects, indicating possible disturbances in brain function. Objective: We aimed to compare serum levels of S100β and NSE between children with and without obesity. Subjects and methods: We analyzed circulating S100β and NSE and performed correlations with anthropometry and biochemical parameters from 80 children between 6 and 11 years old, divided into two groups: children with obesity (Body mass index ≥97th percentile) and children with normal body weight (between the 5th and 85th percentile). Results: Our results show that children with obesity have approximately 50% more circulating levels of S100β and NSE. Furthermore, we found a positive correlation between S100β and circulating resistin and a positive correlation between NSE and Body mass index, waist circumference, and waist-to-hip ratio. Conversely, NSE and adiponectin showed a negative correlation. Conclusion: S100β and NSE levels in blood were associated with indicators of metabolic impairment. Future studies are needed to determine if the increase of S100β and NSE in children with obesity is related to cognitive function.
- 24 November 2025
- Published by Springer Nature in International Journal of Obesity
- Vol. 50 (2) , 378-385
Open AccessSerum S100β and neuron-specific enolase correlate with obesity parameters in Mexican children
Background: Circulating S100 β and neuron-specific enolase (NSE) have been used to explore brain damage in adults with obesity. Nonetheless, the subtle increase of these molecules can be found in non-pathological conditions in healthy subjects, indicating possible disturbances in brain function. Objective: We aimed to compare serum levels of S100β and NSE between children with and without obesity. Subjects and methods: We analyzed circulating S100β and NSE and performed correlations with anthropometry and biochemical parameters from 80 children between 6 and 11 years old, divided into two groups: children with obesity (Body mass index ≥97th percentile) and children with normal body weight (between the 5th and 85th percentile). Results: Our results show that children with obesity have approximately 50% more circulating levels of S100β and NSE. Furthermore, we found a positive correlation between S100β and circulating resistin and a positive correlation between NSE and Body mass index, waist circumference, and waist-to-hip ratio. Conversely, NSE and adiponectin showed a negative correlation. Conclusion: S100β and NSE levels in blood were associated with indicators of metabolic impairment. Future studies are needed to determine if the increase of S100β and NSE in children with obesity is related to cognitive function.
- Open Access
Potential Effects of Nicotinamide on Serum HDL-Cholesterol Levels and Hepatic Oxidative Stress, ABCA1 Gene and Protein Expression in Rats Fed a High-Fat/Fructose Diet
A hypercaloric diet is associated with oxidative stress and the dysfunction of ATP-Binding Cassette transporter A1 (ABCA1), a key element in high-density lipoprotein (HDL) biogenesis and reverse cholesterol transport. Nicotinamide (NAM) presents antioxidant properties, which may contribute to maintaining lipid metabolism. Therefore, we aimed to evaluate the effect of NAM on HDL-cholesterol (HDL-C) level, oxidative stress markers, and the gene expression and protein levels of ABCA1 in Sprague-Dawley rats fed a hypercaloric diet. Forty male rats were divided into five groups: one group received a standard diet, and the remaining groups received a single high-fat, high-fructose diet (HFDF). Three of the HFDF groups received NAM treatment (5, 10, and 15 mM) in drinking water for 16 weeks (5 h/day). While HDL-C and oxidative stress were measured in serum samples, oxidative stress markers, and the gene expression and protein levels of ABCA1 were quantified in liver samples. The HDL-C level altered by the HFDF was improved by treatment with NAM. Furthermore, NAM reduces systemic lipid peroxidation levels and enhances the hepatic antioxidant response affected by the HFDF. In addition, NAM modulates the hepatic ABCA1 gene expression and protein level, altered by the HFDF. Our results suggest that NAM may modify the serum HDL-C level by an improvement of antioxidant response, and a possible modulation of the hepatic ABCA1 gene and protein expression. Further metabolic and molecular studies are needed to support the potential therapeutic role of NAM to prevent or treat lipid alterations promoted by a hypercaloric diet.
Open AccessPotential Effects of Nicotinamide on Serum HDL-Cholesterol Levels and Hepatic Oxidative Stress, ABCA1 Gene and Protein Expression in Rats Fed a High-Fat/Fructose Diet
A hypercaloric diet is associated with oxidative stress and the dysfunction of ATP-Binding Cassette transporter A1 (ABCA1), a key element in high-density lipoprotein (HDL) biogenesis and reverse cholesterol transport. Nicotinamide (NAM) presents antioxidant properties, which may contribute to maintaining lipid metabolism. Therefore, we aimed to evaluate the effect of NAM on HDL-cholesterol (HDL-C) level, oxidative stress markers, and the gene expression and protein levels of ABCA1 in Sprague-Dawley rats fed a hypercaloric diet. Forty male rats were divided into five groups: one group received a standard diet, and the remaining groups received a single high-fat, high-fructose diet (HFDF). Three of the HFDF groups received NAM treatment (5, 10, and 15 mM) in drinking water for 16 weeks (5 h/day). While HDL-C and oxidative stress were measured in serum samples, oxidative stress markers, and the gene expression and protein levels of ABCA1 were quantified in liver samples. The HDL-C level altered by the HFDF was improved by treatment with NAM. Furthermore, NAM reduces systemic lipid peroxidation levels and enhances the hepatic antioxidant response affected by the HFDF. In addition, NAM modulates the hepatic ABCA1 gene expression and protein level, altered by the HFDF. Our results suggest that NAM may modify the serum HDL-C level by an improvement of antioxidant response, and a possible modulation of the hepatic ABCA1 gene and protein expression. Further metabolic and molecular studies are needed to support the potential therapeutic role of NAM to prevent or treat lipid alterations promoted by a hypercaloric diet.
- Open Access
Altered Expression of the MEG3, FTO, ATF4, and Lipogenic Genes in PBMCs from Children with Obesity and Its Associations with Added Sugar Intake
Background: Obesity and its complications have increased in both adults and children, with pediatric populations developing metabolic disorders at earlier ages. Long non-coding RNAs, particularly MEG3, are involved in obesity through regulation of lipogenic genes including ATF4, FTO, SREBP1, FASN, and ACACA. However, data on MEG3 expression in pediatric obesity are limited. This study evaluated MEG3, FTO, and ATF4 expression in PBMCs from children with obesity and their associations with added sugar intake and lipid metabolism genes. Methods: In this cross-sectional study 71 children within the age range of 6 to 12 years were included (28 normal weight and 43 with obesity). Anthropometrical and clinical parameters and dietary added sugar consumption were analyzed. Real-time PCR was performed to assess MEG3, FTO, ATF4, SREBP1, FASN, and ACACA gene expression in peripheral blood mononuclear cells. Results: The expression of MEG3, ATF4, FTO, SREBP1, FASN, and ACACA was decreased in children with obesity. MEG3 and FTO showed sex-dependent expression in children without obesity, while additional sex-related differences were observed for SREBP1, FASN, ACACA, FTO, and MEG3 in children with obesity. MEG3 was associated with the expression of SREBP1, FASN, ACACA, FTO, and ATF4. In insulin-resistant (IR) children, MEG3, ATF4, FTO, ACACA, and SREBP1 were reduced, while FASN was increased. Added sugar intake negatively correlated with FTO, SREBP1, and ACACA. Conclusions: The MEG3, FTO, and ATF4 expression was altered in children with obesity, showing sex- and IR-related differences. Added sugar intake correlated negatively with lipogenic gene expression.
Open AccessAltered Expression of the MEG3, FTO, ATF4, and Lipogenic Genes in PBMCs from Children with Obesity and Its Associations with Added Sugar Intake
Background: Obesity and its complications have increased in both adults and children, with pediatric populations developing metabolic disorders at earlier ages. Long non-coding RNAs, particularly MEG3, are involved in obesity through regulation of lipogenic genes including ATF4, FTO, SREBP1, FASN, and ACACA. However, data on MEG3 expression in pediatric obesity are limited. This study evaluated MEG3, FTO, and ATF4 expression in PBMCs from children with obesity and their associations with added sugar intake and lipid metabolism genes. Methods: In this cross-sectional study 71 children within the age range of 6 to 12 years were included (28 normal weight and 43 with obesity). Anthropometrical and clinical parameters and dietary added sugar consumption were analyzed. Real-time PCR was performed to assess MEG3, FTO, ATF4, SREBP1, FASN, and ACACA gene expression in peripheral blood mononuclear cells. Results: The expression of MEG3, ATF4, FTO, SREBP1, FASN, and ACACA was decreased in children with obesity. MEG3 and FTO showed sex-dependent expression in children without obesity, while additional sex-related differences were observed for SREBP1, FASN, ACACA, FTO, and MEG3 in children with obesity. MEG3 was associated with the expression of SREBP1, FASN, ACACA, FTO, and ATF4. In insulin-resistant (IR) children, MEG3, ATF4, FTO, ACACA, and SREBP1 were reduced, while FASN was increased. Added sugar intake negatively correlated with FTO, SREBP1, and ACACA. Conclusions: The MEG3, FTO, and ATF4 expression was altered in children with obesity, showing sex- and IR-related differences. Added sugar intake correlated negatively with lipogenic gene expression.
- 26 July 2025
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 80 (1) , 73-78
Association of serum total antioxidant capacity and uric acid with obesity and cardiometabolic traits in Mexican children
Background/objectives Serum total antioxidant capacity (sTAC) and uric acid (SUA) levels have been related to oxidative stress in metabolic diseases. Nevertheless, the evidence in epidemiological studies is still scarce and inconsistent. We aimed to evaluate the association between sTAC, SUA, obesity, and cardiometabolic traits in Mexican children. Subjects/methods This cross-sectional study analyzed anthropometric data, blood pressure, cardiometabolic traits, and SUA levels of 248 children with normal weight (NW) and 255 with obesity (OB). sTAC was measured with the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method. Results sTAC was directly related to SUA (β = 0.905 ± 0.358, p = 0.012). Obesity was positively associated with sTAC (β = 0.075 ± 0.020, p < 0.001) and SUA (β = 0.706 ± 0.129, p < 0.001). sTAC was negatively associated with diastolic blood pressure (β = -8.458 ± 3.758, p = 0.026) in NW children and positively associated with insulin (β = 9.511 ± 3.107, p = 0.002) and the homeostatic model assessment of insulin resistance (β = 2.065 ± 0.680, p = 0.003) in OB children. SUA showed negative associations with total cholesterol (β = -4.062 ± 1.340, p = 0.003) and low-density lipoprotein cholesterol (β = -2.470 ± 1.190, p = 0.039) in NW children and high-density lipoprotein cholesterol (β = -1.306 ± 0.409, p < 0.01) in OB children. Conclusion sTAC and SUA are positively associated and are increased in obesity. According to weight status, sTAC and SUA are associated with blood pressure, insulin resistance markers, and lipid profile.
- 26 July 2025
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 80 (1) , 73-78
Association of serum total antioxidant capacity and uric acid with obesity and cardiometabolic traits in Mexican children
Background/objectives Serum total antioxidant capacity (sTAC) and uric acid (SUA) levels have been related to oxidative stress in metabolic diseases. Nevertheless, the evidence in epidemiological studies is still scarce and inconsistent. We aimed to evaluate the association between sTAC, SUA, obesity, and cardiometabolic traits in Mexican children. Subjects/methods This cross-sectional study analyzed anthropometric data, blood pressure, cardiometabolic traits, and SUA levels of 248 children with normal weight (NW) and 255 with obesity (OB). sTAC was measured with the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method. Results sTAC was directly related to SUA (β = 0.905 ± 0.358, p = 0.012). Obesity was positively associated with sTAC (β = 0.075 ± 0.020, p < 0.001) and SUA (β = 0.706 ± 0.129, p < 0.001). sTAC was negatively associated with diastolic blood pressure (β = -8.458 ± 3.758, p = 0.026) in NW children and positively associated with insulin (β = 9.511 ± 3.107, p = 0.002) and the homeostatic model assessment of insulin resistance (β = 2.065 ± 0.680, p = 0.003) in OB children. SUA showed negative associations with total cholesterol (β = -4.062 ± 1.340, p = 0.003) and low-density lipoprotein cholesterol (β = -2.470 ± 1.190, p = 0.039) in NW children and high-density lipoprotein cholesterol (β = -1.306 ± 0.409, p < 0.01) in OB children. Conclusion sTAC and SUA are positively associated and are increased in obesity. According to weight status, sTAC and SUA are associated with blood pressure, insulin resistance markers, and lipid profile.
- Open Access
- 22 July 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (8) , 896
Genetic Variants in Antioxidant Genes Modulate the Relationships Among Obesity-Related Oxidative Stress Markers in Mexican Children
Single-nucleotide polymorphisms (SNPs) in antioxidant genes could influence redox regulation from early life. We aimed to assess the direct and modulatory effects of SNPs in antioxidant genes (SOD2 rs4880, GPX1 rs1050450, GPX7 rs835337, CAT rs1001179) on the relationships among obesity-related oxidative stress markers in Mexican children. Anthropometric data of 2946 unrelated children were analyzed in this cross-sectional study. SNPs were genotyped using TaqMan assay. Serum total antioxidant capacity (sTAC) and oxidative stress markers (thiobarbituric acid reactive substances [TBARS, as lipid peroxidation], and protein carbonyl [PC]) were assessed. Although no SNPs were associated with obesity (p ≥ 0.125), both sTAC (p = 0.001) and TBARS (p = 0.015) were positively associated with it. A negative relationship was also observed between sTAC and TBARS (p < 0.001). SOD2 rs4880 was negatively associated with TBARS, while GPX1 rs1050450 was inversely associated with both TBARS and PC levels (p ≤ 0.036). The inverse association between sTAC and TBARS remained significant only in non-carriers of SOD2 rs4880 (p = 0.003) and GPX1 rs1050450 (p = 0.002). Our data evidence that sTAC and TBARS are associated with obesity, showing a negative relationship in Mexican children who are non-carriers of SOD2 rs4880 and GPX1 rs1050450.
- 22 July 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (8) , 896
Open AccessGenetic Variants in Antioxidant Genes Modulate the Relationships Among Obesity-Related Oxidative Stress Markers in Mexican Children
Single-nucleotide polymorphisms (SNPs) in antioxidant genes could influence redox regulation from early life. We aimed to assess the direct and modulatory effects of SNPs in antioxidant genes (SOD2 rs4880, GPX1 rs1050450, GPX7 rs835337, CAT rs1001179) on the relationships among obesity-related oxidative stress markers in Mexican children. Anthropometric data of 2946 unrelated children were analyzed in this cross-sectional study. SNPs were genotyped using TaqMan assay. Serum total antioxidant capacity (sTAC) and oxidative stress markers (thiobarbituric acid reactive substances [TBARS, as lipid peroxidation], and protein carbonyl [PC]) were assessed. Although no SNPs were associated with obesity (p ≥ 0.125), both sTAC (p = 0.001) and TBARS (p = 0.015) were positively associated with it. A negative relationship was also observed between sTAC and TBARS (p < 0.001). SOD2 rs4880 was negatively associated with TBARS, while GPX1 rs1050450 was inversely associated with both TBARS and PC levels (p ≤ 0.036). The inverse association between sTAC and TBARS remained significant only in non-carriers of SOD2 rs4880 (p = 0.003) and GPX1 rs1050450 (p = 0.002). Our data evidence that sTAC and TBARS are associated with obesity, showing a negative relationship in Mexican children who are non-carriers of SOD2 rs4880 and GPX1 rs1050450.
- Open Access
- 11 July 2025
- Published by MDPI AG in Preprints.org
Altered Expression of the MEG3–FTO–ATF4 Axis and Lipid Metabolism Genes in PBMCs from Children with Obesity and Its Associations and Added Sugar Intake
Background: Obesity and its complications have increased in both adults and children, with pediatric populations developing metabolic disorders earlier ages. Long non-coding RNAs, particularly MEG3, are involved in obesity through regulation of lipid metabolism genes including ATF4, FTO, SREBP1, FASN, and ACACA. However, data on MEG3 expression in pediatric obesity are limited. This study evaluated MEG3, FTO, and ATF4 expression in PBMCs from children with obesity and their associations with added sugar intake and lipid metabolism genes. Methods: In this cross-sectional study a total of 71 children aged of 6 to 12 years were included (28 normal weight and 43 with obesity). Anthropometrical and clinical parameters and dietary added sugar consumption were analyzed. Real-time PCR was performed to assess MEG3, FTO, ATF4, SREBP1, FASN and ACACA gene expression in peripheral blood mononuclear cells. Results: The expression of MEG3, ATF4, FTO, SREBP1, FASN, and ACACA was decreased in children with obesity. MEG3 and FTO showed sex-dependent expression in children without obesity, while additional sex-related differences were observed for SREBP1, FASN, ACACA, FTO, and MEG3 in children with obesity. MEG3 was correlated with increased levels of ATF4 and SREBP1, and moderately with FTO and FASN. In insulin resistance (IR) children, MEG3, ATF4, FTO, ACACA, and SREBP1 were reduced, while FASN was increased. Added sugar intake negatively correlated with FTO, SREBP1, and ACACA. Conclusions: The MEG3–FTO–ATF4 axis was altered in children with obesity, showing sex- and IR-related differences. Added sugar intake correlated negatively with lipid metabolism gene expression.
- 11 July 2025
- Published by MDPI AG in Preprints.org
Open AccessAltered Expression of the MEG3–FTO–ATF4 Axis and Lipid Metabolism Genes in PBMCs from Children with Obesity and Its Associations and Added Sugar Intake
Background: Obesity and its complications have increased in both adults and children, with pediatric populations developing metabolic disorders earlier ages. Long non-coding RNAs, particularly MEG3, are involved in obesity through regulation of lipid metabolism genes including ATF4, FTO, SREBP1, FASN, and ACACA. However, data on MEG3 expression in pediatric obesity are limited. This study evaluated MEG3, FTO, and ATF4 expression in PBMCs from children with obesity and their associations with added sugar intake and lipid metabolism genes. Methods: In this cross-sectional study a total of 71 children aged of 6 to 12 years were included (28 normal weight and 43 with obesity). Anthropometrical and clinical parameters and dietary added sugar consumption were analyzed. Real-time PCR was performed to assess MEG3, FTO, ATF4, SREBP1, FASN and ACACA gene expression in peripheral blood mononuclear cells. Results: The expression of MEG3, ATF4, FTO, SREBP1, FASN, and ACACA was decreased in children with obesity. MEG3 and FTO showed sex-dependent expression in children without obesity, while additional sex-related differences were observed for SREBP1, FASN, ACACA, FTO, and MEG3 in children with obesity. MEG3 was correlated with increased levels of ATF4 and SREBP1, and moderately with FTO and FASN. In insulin resistance (IR) children, MEG3, ATF4, FTO, ACACA, and SREBP1 were reduced, while FASN was increased. Added sugar intake negatively correlated with FTO, SREBP1, and ACACA. Conclusions: The MEG3–FTO–ATF4 axis was altered in children with obesity, showing sex- and IR-related differences. Added sugar intake correlated negatively with lipid metabolism gene expression.
- Open Access
- 1 January 2025
- Published by Revista Mexicana de Ingenieria Biomedica in Revista Mexicana de Ingeniería Biomédica
- Vol. 46 (1) , e1480-66
Synthetic Data Generation for Pediatric Diabetes Research Using GANs and WGANs
Pediatric diabetes research is often constrained by data scarcity, hindering the development of accurate predictive models for clinical applications. This study addresses this limitation by evaluating the effectiveness of Generative Adversarial Networks (GANs) and Wasserstein GANs (WGANs) in generating synthetic datasets that replicate the statistical properties of real pediatric diabetes data. A structured methodology was applied, incorporating preprocessing, model design, and dual evaluation metrics: Jensen-Shannon and Kullback-Leibler divergences for statistical fidelity, and a classification model to assess practical utility. Results demonstrate that both models produce high-fidelity synthetic datasets, with WGANs showing superior performance in capturing complex patterns due to improved training stability. Nonetheless, challenges remain in replicating the inherent variability of pediatric data, influenced by growth and developmental factors. This work highlights the potential of synthetic data to augment pediatric diabetes datasets, facilitating the development of robust and generalizable predictive models. Limitations include the dependency on initial data quality and the specificity of the models to pediatric datasets. By addressing critical gaps in data availability, this study contributes to advancing AI-driven healthcare solutions in pediatric diabetes research.
- 1 January 2025
- Published by Revista Mexicana de Ingenieria Biomedica in Revista Mexicana de Ingeniería Biomédica
- Vol. 46 (1) , e1480-66
Open AccessSynthetic Data Generation for Pediatric Diabetes Research Using GANs and WGANs
Pediatric diabetes research is often constrained by data scarcity, hindering the development of accurate predictive models for clinical applications. This study addresses this limitation by evaluating the effectiveness of Generative Adversarial Networks (GANs) and Wasserstein GANs (WGANs) in generating synthetic datasets that replicate the statistical properties of real pediatric diabetes data. A structured methodology was applied, incorporating preprocessing, model design, and dual evaluation metrics: Jensen-Shannon and Kullback-Leibler divergences for statistical fidelity, and a classification model to assess practical utility. Results demonstrate that both models produce high-fidelity synthetic datasets, with WGANs showing superior performance in capturing complex patterns due to improved training stability. Nonetheless, challenges remain in replicating the inherent variability of pediatric data, influenced by growth and developmental factors. This work highlights the potential of synthetic data to augment pediatric diabetes datasets, facilitating the development of robust and generalizable predictive models. Limitations include the dependency on initial data quality and the specificity of the models to pediatric datasets. By addressing critical gaps in data availability, this study contributes to advancing AI-driven healthcare solutions in pediatric diabetes research.